AbbVie to buy Landos to expand pipeline of immunity-related illnesses

(Reuters) – AbbVie said on Monday it would acquire drug developer Landos Biopharma for up to $212 million as the Humira-maker aims to expand its pipeline of medicines to treat immune system-related illnesses.

(Reporting by Leroy Leo in Bengaluru; Editing by Sriraj Kalluvila)